– Assets expand immunology portfolio to include B-cell therapy (BAFF/APRIL) and macrophage modulation – – IND-enabling studies are ongoing and will support the transition of these assets to clinical development… Read More
VANCOUVER, BC– (GLOBE NEWSWIRE) — In a recent announcement Life Sciences BC awarded Novateur Ventures the ‘2021 Strategic Life Sciences Partner of the Year’ for its outstanding contribution to the province’s life sciences… Read More
75,000-square foot facility will be home to PNI’s new global headquarters and will include multiple GMP (Good Manufacturing Practice) suites for manufacturing RNA therapeutics and vaccines PNI’s Biomanufacturing Centre is… Read More
VANCOUVER, BC — GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical-stage pharmaceutical development company, is pleased to announce that it… Read More
Vancouver, BC –(Newsfile Corp.) – iCo Therapeutics Inc. (TSXV: ICO) (OTCQB: ICOTF) (“iCo” or the “Company”) is pleased to announce that at an annual and special meeting of the Company… Read More
